151 related articles for article (PubMed ID: 26857279)
1. Clinical impact of circulating microRNAs as blood-based marker in childhood acute lymphoblastic leukemia.
Swellam M; El-Khazragy N
Tumour Biol; 2016 Aug; 37(8):10571-6. PubMed ID: 26857279
[TBL] [Abstract][Full Text] [Related]
2. Aberrant Expression of Some Circulating miRNAs in Childhood Acute Lymphoblastic Leukemia.
Swellam M; Hashim M; Mahmoud MS; Ramadan A; Hassan NM
Biochem Genet; 2018 Aug; 56(4):283-294. PubMed ID: 29460192
[TBL] [Abstract][Full Text] [Related]
3. [Association between expression of plasma miRNA and the risk of childhood acute lymphocytic leukemia].
Yuan DM; Wu SY; Huang SL; Jiang WC; Ke YB
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep; 38(9):1252-1258. PubMed ID: 28910942
[No Abstract] [Full Text] [Related]
4. Circulating microRNA expression profile in B-cell acute lymphoblastic leukemia.
Luna-Aguirre CM; de la Luz Martinez-Fierro M; Mar-Aguilar F; Garza-Veloz I; Treviño-Alvarado V; Rojas-Martinez A; Jaime-Perez JC; Malagon-Santiago GI; Gutierrez-Aguirre CH; Gonzalez-Llano O; Salazar-Riojas R; Hidalgo-Miranda A; Martinez-Rodriguez HG; Gomez-Almaguer D; Ortiz-Lopez R
Cancer Biomark; 2015; 15(3):299-310. PubMed ID: 26406572
[TBL] [Abstract][Full Text] [Related]
5. Circulating miR-146a expression as a non-invasive predictive biomarker for acute lymphoblastic leukemia.
Shahid S; Shahid W; Shaheen J; Akhtar MW; Sadaf S
Sci Rep; 2021 Nov; 11(1):22783. PubMed ID: 34815474
[TBL] [Abstract][Full Text] [Related]
6. Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features.
de Oliveira JC; Scrideli CA; Brassesco MS; Morales AG; Pezuk JA; Queiroz Rde P; Yunes JA; Brandalise SR; Tone LG
Leuk Res; 2012 Mar; 36(3):293-8. PubMed ID: 22099053
[TBL] [Abstract][Full Text] [Related]
7. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.
Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M
Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043
[TBL] [Abstract][Full Text] [Related]
8. Follow-up of minimal residual disease in acute childhood lymphoblastic leukemia by WT1 gene expression in the peripheral blood: the Hungarian experience.
Magyarosy E; Varga N; Timár J; Rásó E
Pediatr Hematol Oncol; 2003; 20(1):65-74. PubMed ID: 12687755
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA as a diagnostic biomarker in childhood acute lymphoblastic leukemia; systematic review, meta-analysis and recommendations.
Rashed WM; Hammad AM; Saad AM; Shohdy KS
Crit Rev Oncol Hematol; 2019 Apr; 136():70-78. PubMed ID: 30878131
[TBL] [Abstract][Full Text] [Related]
10. [Expression and Clinical Significance of MiR-146a and MiR-221 in Childhood Acute T Lymphoblastic Leukemia].
Li SW; Li H; Zhang ZP; Zhuo F; Li ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):436-441. PubMed ID: 32319375
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of whole genome microRNA expression profiling in childhood acute lymphoblastic leukemia.
Duyu M; Durmaz B; Gunduz C; Vergin C; Yilmaz Karapinar D; Aksoylar S; Kavakli K; Cetingul N; Irken G; Yaman Y; Ozkinay F; Cogulu O
Biomed Res Int; 2014; 2014():967585. PubMed ID: 24955371
[TBL] [Abstract][Full Text] [Related]
12. Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia.
Schotte D; Chau JC; Sylvester G; Liu G; Chen C; van der Velden VH; Broekhuis MJ; Peters TC; Pieters R; den Boer ML
Leukemia; 2009 Feb; 23(2):313-22. PubMed ID: 18923441
[TBL] [Abstract][Full Text] [Related]
13. miRNA-155 and miRNA-181a as prognostic biomarkers for pediatric acute lymphoblastic leukemia.
El-Khazragy N; Noshi MA; Abdel-Malak C; Zahran RF; Swellam M
J Cell Biochem; 2019 Apr; 120(4):6315-6321. PubMed ID: 30362157
[TBL] [Abstract][Full Text] [Related]
14. Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia.
Nemes K; Csóka M; Nagy N; Márk Á; Váradi Z; Dankó T; Kovács G; Kopper L; Sebestyén A
Pathol Oncol Res; 2015 Jul; 21(3):597-604. PubMed ID: 25388103
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA 146a Polymorphisms and Expression in Indian Children with Acute Lymphoblastic Leukemia.
Jemimah Devanandan H; Venkatesan V; Scott JX; Magatha LS; Durairaj Paul SF; Koshy T
Lab Med; 2019 Jul; 50(3):249-253. PubMed ID: 30576465
[TBL] [Abstract][Full Text] [Related]
16. Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia.
Ju X; Li D; Shi Q; Hou H; Sun N; Shen B
Pediatr Hematol Oncol; 2009 Jan; 26(1):1-10. PubMed ID: 19206004
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-181a and its target Smad 7 as potential biomarkers for tracking child acute lymphoblastic leukemia.
Nabhan M; Louka ML; Khairy E; Tash F; Ali-Labib R; El-Habashy S
Gene; 2017 Sep; 628():253-258. PubMed ID: 28732737
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of MicroRNA92, MicroRNA638 in Acute Lymphoblastic Leukemia of Egyptian Children.
Fayed D; Donia T; El-Shanshory M; Ali EMM; Mohamed TM
Asian Pac J Cancer Prev; 2021 May; 22(5):1567-1572. PubMed ID: 34048187
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and prognostic significance of murine double minute protein-2 overexpression and P53 gene mutations in childhood acute lymphoblastic leukemia.
Hendy OM; Elghannam DM; El-Sharnouby JA; Goda EF; El-Ashry R; Al-Tonbary Y
Egypt J Immunol; 2008; 15(1):93-100. PubMed ID: 20306673
[TBL] [Abstract][Full Text] [Related]
20. Low Expression of miR-18a as a Characteristic of Pediatric Acute Lymphoblastic Leukemia.
Mosakhani N; Missiry ME; Vakkila E; Knuutila S; Vakkila J
J Pediatr Hematol Oncol; 2017 Nov; 39(8):585-588. PubMed ID: 29068867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
